5,458
Views
23
CrossRef citations to date
0
Altmetric
State of the Art Reviews

Cinacalcet versus standard treatment for chronic kidney disease: a systematic review and meta-analysis

, , , , , , , & show all
Pages 857-874 | Received 17 Jan 2016, Accepted 21 Mar 2016, Published online: 02 May 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Tibor Fülöp. (2019) Greetings to the readers. Renal Failure 41:1, pages 69-71.
Read now

Articles from other publishers (22)

Haoyang Lu, Tingting Guo, Shanqing Huang, Yuandan Li, Yuguan Wen, Dewei Shang & Xin Wen. (2023) Development and validation of an LC-MS/MS method by one-step precipitation for cinacalcet in human plasma. Heliyon 9:6, pages e17230.
Crossref
Pía Villarroel Heise, Leopoldo Ardiles Arnaiz, Mariana Cifuentes Köster, Francisca Peña D’Ardaillon, Eduardo Lorca Herrera & Marcela Reyes Jedlicki. (2023) Use of cinacalcet in secondary hyperparathyroidism: assessment of nutritional, lipid and inflammatory status in chronic kidney disease. Nutrición Hospitalaria.
Crossref
Sevcan A. Bakkaloğlu. 2022. Evidence‐Based Nephrology. Evidence‐Based Nephrology 356 378 .
Ivo Mendes de Araújo, Elza Lima da Silva, Aline Lima Pestana Magalhães, Aurean D’Eça Júnior, Flávia Baluz Bezerra de Farias Nunes & Elisângela Milhomem dos Santos. (2021) Deficiência de vitamina D e mortalidade cardiovascular na doença renal crônica: revisão integrativa. Ciência, Cuidado e Saúde 20.
Crossref
Kamyar Asadipooya, Mohamed Abdalbary, Yahya Ahmad, Elijah Kakani, Marie-Claude Monier-Faugere & Amr El-Husseini. (2021) Bone Quality in Chronic Kidney Disease Patients: Current Concepts and Future Directions – Part II. Kidney Diseases 7:5, pages 359-371.
Crossref
Ya-Chen Chou, Yi-Chia Chan, Shun-Yu Chi & Fong-Fu Chou. (2021) Being elderly is not a contraindication of parathyroidectomy for renal hyperparathyroidism and chronic kidney disease-mineral and bone disorder. Asian Journal of Surgery 44:1, pages 321-328.
Crossref
Yiting Sun, Binyao Tian, Zitong Sheng, Pengzhi Wan, Tianhua Xu & Li Yao. (2020) Efficacy and safety of cinacalcet compared with other treatments for secondary hyperparathyroidism in patients with chronic kidney disease or end-stage renal disease: a meta-analysis. BMC Nephrology 21:1.
Crossref
Wenhan Chang, Chia-Ling Tu, Frederic G. Jean-Alphonse, Amanda Herberger, Zhiqiang Cheng, Jenna Hwong, Hanson Ho, Alfred Li, Dawei Wang, Hongda Liu, Alex D. White, Insoo Suh, Wen Shen, Quan-Yang Duh, Elham Khanafshar, Dolores M. Shoback, Kunhong Xiao & Jean-Pierre Vilardaga. (2020) PTH hypersecretion triggered by a GABAB1 and Ca2+-sensing receptor heterocomplex in hyperparathyroidism. Nature Metabolism 2:3, pages 243-255.
Crossref
Hubert Golingan, Shenae K. Samuels, Pauline Camacho, Darshana M. Dadhania, Fernando E. Pedraza-Taborda, Gregory Randolph, Sareh Parangi, David N. Bimston & R. Mack Harrell. (2020) Management of Hyperparathyroidism in Kidney Transplantation Candidates: A Need for Consensus. Endocrine Practice 26:3, pages 299-304.
Crossref
Michihito Wada, Takehisa Kawata & Nobuo Nagano. 2020. Encyclopedia of Bone Biology. Encyclopedia of Bone Biology 697 710 .
Jun Xu, Yan Yang, Liang Ma, Ping Fu & Hongying Peng. (2019) Cinacalcet plus vitamin D versus vitamin D alone for the treatment of secondary hyperparathyroidism in patients undergoing dialysis: a meta-analysis of randomized controlled trials. International Urology and Nephrology 51:11, pages 2027-2036.
Crossref
Miao Long, Qiang-Ming Li, Qing Fang, Li-Hua Pan, Xue-Qiang Zha & Jian-Ping Luo. (2019) Renoprotective Effect of Laminaria japonica Polysaccharide in Adenine-Induced Chronic Renal Failure. Molecules 24:8, pages 1491.
Crossref
Yuan Zu, Xiangxue Lu, Jinghong Song, Ling Yu, Han Li & Shixiang Wang. (2019) Cinacalcet Treatment Significantly Improves All-Cause and Cardiovascular Survival in Dialysis Patients: Results from a Meta-Analysis. Kidney and Blood Pressure Research 44:6, pages 1327-1338.
Crossref
E Mogas, A Campos-Martorell, M Clemente, L Castaño, A Moreno-Galdó, D Yeste & A Carrascosa. (2018) Successful use of cinacalcet to treat parathyroid-related hypercalcemia in two pediatric patients. Endocrinology, Diabetes & Metabolism Case Reports.
Crossref
Carlo Vulpio & Maurizio Bossola. (2017) Parathyroid Nodular Hyperplasia and Responsiveness to Drug Therapy in Renal Secondary Hyperparathyroidism: An Open Question. Therapeutic Apheresis and Dialysis 22:1, pages 11-21.
Crossref
Primploy Greeviroj, Thidarat Kitrungphaiboon, Pisut Katavetin, Kearkiat Praditpornsilpa, Somchai Eiam-Ong, Bertrand L. Jaber & Paweena Susantitaphong. (2018) Cinacalcet for Treatment of Chronic Kidney Disease-Mineral and Bone Disorder: A Meta-Analysis of Randomized Controlled Trials. Nephron 139:3, pages 197-210.
Crossref
Edward F. Nemeth, Bradford C. Van Wagenen & Manuel F. Balandrin. 2018. 1 86 .
Daisuke Takada, Tatsuo Tsukamoto, Miho Fuse, Shinpei Kada & Motoko Yanagita. (2017) The use of cinacalcet hinders the diagnosis of parathyroid carcinoma in a chronic dialysis patient: a case report. BMC Nephrology 18:1.
Crossref
José Ruiz, Antonio Ríos, José Manuel Rodríguez, Santiago Llorente, Luisa Jimeno & Pascual Parrilla. (2017) Calcimimetics have had no impact on the indications for surgery of tertiary hyperparathyroidism. Nefrología (English Edition) 37:6, pages 651-652.
Crossref
José Ruiz, Antonio Ríos, José Manuel Rodríguez, Santiago Llorente, Luisa Jimeno & Pascual Parrilla. (2017) Los calcimiméticos no han tenido impacto en la cirugía del hiperparatiroidismo terciario. Nefrología 37:6, pages 651-653.
Crossref
José Ruiz, Antonio Ríos, José Manuel Rodríguez, Santiago Llorente, Antonio Miguel Hernández & Pascual Parrilla. (2017) Impacto de los calcimiméticos en la cirugía del hiperparatiroidismo secundario. Endocrinología, Diabetes y Nutrición 64:1, pages 59-61.
Crossref
José Ruiz, Antonio Ríos, José Manuel Rodríguez, Santiago Llorente, Antonio Miguel Hernández & Pascual Parrilla. (2017) Impact of calcimimetics in surgery of secondary hyperparathyroidism. Endocrinología, Diabetes y Nutrición (English ed.) 64:1, pages 59-61.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.